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Magazinefor honesty.” So much for Amotz 
Zahavi’s “Handicap Principle” and Alan 
Grafen’s mathematical support for it, in 
which the costs of exaggerated signals 
promote their evolution. In Wiley’s 
model, “honesty and exaggeration in 
noisy communication evolve despite 
costs, rather than because of them.” 
Wiley goes so far as to claim that, 
despite their dominant infl uence on 
the fi eld, previous studies on the costs 
of honest signaling “contribute little 
to understanding the evolution of 
communication.” This view is certain 
to ruffl e some bright, showy tail 
feathers!
Finally, in Part IV (“Far Horizons”), 
Wiley removes the mantle of behavioral 
biologist to don that of philosopher. 
In a series of short chapters, Wiley 
illuminates potentially important 
and underappreciated connections 
between noisy communication and a 
seemingly limitless range of topics, 
including human language and thought, 
self awareness, subjectivity versus 
objectivity, theory of mind, and science 
and skepticism. Wiley freely admits to 
wading into less familiar waters, which 
is apparent in this section’s emphasis 
on breadth instead of depth. Yet his 
reasons for doing so are clear, and 
as to be expected for an evolutionary 
biologist, they are based on a careful 
analysis of benefi ts and costs: 
…as I always reminded my students, 
it is well to keep an eye on the 
horizons around even the most 
focused question. There are fruits to 
be gathered and seeds to be sown 
in distant lands. The challenge, of 
course, is that these horizons, not so 
distant ones even, are already well 
populated by indigenous experts. 
Intrusion inevitably meets resistance, 
although mutual invigoration 
sometimes ensues. 
If the benefi t of invigoration between 
behavioral biology and philosophy is 
truly mutual, then it will surely out-
weigh the inevitable cost of resistance 
that will arise along the way. Wiley’s 
book represents an important, and 
large, fi rst step down this path.
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What turned you on to biology in 
the fi rst place? I am the daughter of 
artists, so I have no idea where my 
interest in science came from — it 
was neither nature nor nurture. It 
may simply have been that I was 
always encouraged to spend lots of 
time outdoors — an interest in fl ora 
and fauna came with the territory. I 
was forever catching bugs in nets 
and looking at pond water under the 
microscope, convinced I might see 
something that someone else had 
missed. Of course I never did, but the 
idea that I might was so compelling. 
That seductive feeling has kept me 
going since.
And what drew you to your specifi c 
fi eld of research? My PhD work 
was in virology, and I’ve always been 
interested in infectious diseases. 
I took a pretty wide detour over 
a 15-year period through cancer, 
apoptosis and cell shape, which 
gave me a diverse and fundamental 
grounding in cell biology, but more 
recently I’ve returned to my initial 
love. I was drawn to the cell biology 
of chronic urinary tract infections 
because it’s a fascinating problem 
involving clever bacterial subversion 
of host cell processes: certain species 
can invade the cell and form long-
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very little is known at the molecular 
level. But it wasn’t just the science: 
a passionate clinician I met at a 
cocktail party persuaded me that it’s a 
serious medical problem that few are 
addressing. Cell shape had become 
far too abstract for me — I had been 
hoping to make more of a difference 
to patients and to work more closely 
with them. When this clinician offered 
me the chance to run his lab, I leapt 
at the chance.
If you had to choose a different 
fi eld of biology, what would it be? 
I’m not sure, but I suspect if I could 
do it all over again, I’d become a 
doctor. Medics can do great lab 
research if they want, but they have a 
better career structure — there’s a job 
for everyone, and if that grant doesn’t 
come through, they can always go 
back to the wards. And I like the idea 
of affecting health from inside as well 
as out.
Do you have a scientifi c hero (dead 
or alive)? I’ve always admired Peyton 
Rous, the man who discovered tumor 
viruses. He slogged through day after 
day, grinding up tumors and injecting 
them into chickens until he fi nally 
struck gold. He’s a great example of 
how science is more about hunches, 
luck and hard work than anything 
else — it’s a lesson all researchers 
should take to heart.
What is the best advice you’ve been 
given? Life begins at 40. 
You do a lot of writing and 
broadcast work, and have 
published two novels. How do you 2015 Elsevier Ltd All rights reserved R739
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the lab? I’m very structured with my 
time. I exercise over lunch breaks and 
don’t waste time watching television; 
I do work evenings and weekends, 
but that’s on other things like writing. 
When I’m in the lab, I focus solely on 
the science, but I don’t take my work 
home with me that often. I have a 
baby son, which has made everything 
that much more challenging — when 
I have to leave at 4pm to pick him 
up, it’s non-negotiable. I did the 
whole 80-hour week thing in graduate 
school and in my fi rst post-doc, 
because that was the done thing, but 
it doesn’t work for me now. I fi nd that 
I’m a better scientist if I have a better 
work–life balance. When you work too 
many hours, you just make mistakes. I 
appear to be just as effi cient as far as 
output compared with colleagues who 
regularly pull all-nighters, so I must be 
doing something right.
Do you think your writing and 
public engagement activities 
work against you? I think there is a 
certain phenotype of academic who 
disapproves of scientists who do lots 
of other things: how can I possibly be 
serious if I’ve written a novel or have 
been on the radio or have given talks 
to school kids? But I’m serious about 
science as a whole, which is why I like 
to explore it from all angles, including 
culturally. And science needs 
advocates — we rely primarily on the 
public for funding, so we ignore them 
at our peril.
Tell us more about your interest 
in fi ction. It all started back when I 
was a graduate student in Seattle in 
the early 1990s. I was given a copy 
of Cantor’s Dilemma by the late Carl 
Djerassi — a tale about an ambitious 
scientist who wants to win the Nobel 
Prize. It really blew me away because 
I couldn’t remember ever having read 
a novel with a scientist as a central 
character — outside of science 
fi ction. When I went to look for more 
‘normal’ novels about science as 
a profession, I only found about a 
handful of books. So I coined the 
term ‘lablit’ as a thought experiment 
and decided to rustle up more interest 
in the genre. I eventually founded 
LabLit.com, which just had its ten-
year anniversary, to help highlight the R740 Current Biology 25, R733–R752, Auguscause. And I wrote two novels about 
scientists — Experimental Heart and 
The Honest Look, both published by 
Cold Spring Harbor Laboratory Press. 
LabLit.com has found fame of sorts, 
having been featured in the New York 
Times and on US National Public 
Radio, and has many loyal followers. 
We’ve published lots of great short 
fi ction about scientists, about which 
I’m enormously proud. Since founding 
the site there has been an upswing 
in interest in novels with science in 
them, but there are still only about 
200 books ever written that feature 
scientists — which is a pretty poor 
showing. So there’s more work to be 
done. Fiction is a great stealth media 
to reveal to people what really goes 
on in labs, and in the hearts and souls 
of the scientists who inhabit them. 
A few hundred people might visit a 
science museum, but a bestselling 
novel made into a blockbuster 
Hollywood fi lm can reach millions.
What’s your favourite experiment? 
I love doing western blots, the old 
fashioned way, pouring your own 
polyacrylamide gels. People laugh 
at me for not using the ready-made 
stuff, but I enjoy the rituals. Most of 
the most exciting results of my youth 
came out of the developer at 3am.
What has been your biggest 
mistake...? Listening to people who 
said I didn’t have what it takes to 
make it in science. Luckily I didn’t 
listen for long.
Do you feel a push towards more 
applied science? How does that 
affect your own work? Defi nitely 
yes. It’s all very well to work in the 
abstract, but in recent years it has not 
satisfi ed the yearning I have always 
had to make a difference to actual 
people. I took a turn into biotech for 
a few years for precisely that reason, 
and it was eye-opening. I know we 
need fundamental discoveries to 
feed the pipeline, but I’ve spent a lot 
of time at the purely basic end and 
now I want to be closer to the fi nish 
line. Some of the work my team is 
doing with nanoencapsulated drugs 
is gearing up for clinical trials, and 
it’s very exciting to see the initial 
ideas translate into something more 
concrete.t 31, 2015 ©2015 Elsevier Ltd All rights reserveYou are founder and chair of 
Science is Vital — what’s that all 
about? Back in 2010 in the UK, a 
politician gave a speech threatening 
major cuts to science funding. A 
lot of people were muttering about 
it on social media, in a very British 
way, but I got angry and wrote an 
American-style blog suggesting that 
scientists actually do something 
about it, and rise up in protest. I had 
no idea it would actually happen,  but 
within a few hours the website had 
crashed from so many people leaving 
comments saying that they wanted 
to join in. Science is Vital was born: a 
grassroots organization to lobby for 
protection of research funding in the 
UK. We had our demo in the end, four 
weeks later in front of the Treasury — 
a few thousand scientists in white 
coats with amusing placards and 
off-key singing. It was brilliant: we got 
amazing press coverage because the 
spectacle of scientists on the street 
was pretty unusual. Government 
sources told us that our campaign 
helped make a difference, and we’re 
still active to this day. But I don’t ever 
want to organize a major demo in only 
one month ever again!
Any strong views on social 
media and science? I am a strong 
proponent of scientists getting their 
work out there, and social media is a 
great way to reach a new audience. 
But it’s also quite useful for facilitating 
your own science. Within about fi ve 
minutes of tweeting a question about 
how to do an experiment, I usually 
have about ten useful replies. But 
there has been a lot of criticism of 
social media recently, for example 
during the Tim Hunt affair. In my view, 
social media gives a voice to people 
who are not privileged to have the 
platform of major news sites — in 
other words, ordinary scientists, as 
opposed to the great and the good. 
A lot of jobbing women scientists 
took to Twitter to air their views in a 
balanced way — but the press has 
vilifi ed them as a ‘lynch mob’, ‘witch 
hunt’ and worse, and I know many 
who are now scared to speak out. I 
sometimes think that the mainstream 
press feels threatened by social 
media because it can’t control the 
message: but it’s silly to blame the 
platform, and to blame people for d
Current Biology
Magazineairing their opinions on it. Actions 
have consequences, and social 
media makes things happen faster; 
this sometimes means that people 
can’t get away with saying ill-advised 
things that in the past would have 
fallen on only a few ears. I think it 
remains enormously important for 
scientists — especially young ones, 
like PhD students and postdocs — to 
be able to have their balanced and 
respectful say without fear of reprisal.
Did those recent events have 
anything good fall out of them? 
Well, it was pretty amazing to see the 
issues of gender parity in science be 
front-page news for several weeks on 
end. People were talking openly and 
passionately about a topic that still 
touches a nerve — and the reason 
it does is because it’s still such a 
problem. Any PhD or postdoc in the 
life sciences today will still wonder 
why, considering initial cohorts 
composed equally of men and women, 
fewer than 20% of professors are 
female. We have seen gender parity 
at the time that scientists embark on 
their research careers since about the 
late 1980s/early 1990s, but women 
continue to hemorrhage out of the 
system at an alarming rate. There are 
many reasons why and it’s horribly 
complicated — but we as a community 
need to keep having this discussion 
until the problem is solved. 
Which aspect of science, your fi eld 
or in general, would you wish the 
general public knew more about? 
I wish more people knew what science 
was really like — that scientists are 
real people, not stereotypes, and 
that science is not black and white. 
A fundamental misunderstanding of 
how science works breeds a lot of 
mistrust and pseudoscientifi c thinking. 
Scientists need to be open about what 
they’re doing and how they do it if they 
want their messages to be trusted. 
As long as people suspect we’re evil 
geniuses working in secret labs to build 
a clone army, there will always be a lack 
of trust.
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What is a killifi sh? Killifi shes are 
a diverse group of small, mainly 
freshwater fi shes that are often found in 
marginal habitats not occupied by other 
fi sh species — from tropical mangrove 
tidal zones inhabited by the amphibious 
and self-fertilizing hermaphroditic 
Kryptolebias marmoratus, to cold lakes 
on the Andean plateau occupied by 
the endemic Orestias species fl ock. 
As adaptations to these marginal 
habitats, killifi sh possess some unusual 
reproductive strategies.
What is so special about the 
turquoise killifi sh? The turquoise 
killifi sh (Nothobranchius furzeri), along 
with over 60 other species in the genus 
Nothobranchius, inhabits temporary 
pools on the African savannah. Here, 
the killifi sh have pushed adaptation to 
marginal habitats to the extreme. They 
have evolved special adaptations that 
allow them to survive the complete 
annual desiccation of their habitat. While 
adults die during dry periods, developing 
embryos survive, encased in dry mud in a 
dormant state, termed ‘diapause’, where 
development is completely arrested.
Is embryonic diapause unique to 
killifi sh? For a vertebrate, diapause 
is extremely unusual but not unique. 
By contrast, many non-vertebrates 
and plants have diapause stages, 
forming seed or egg banks in the soil. 
In killifi shes it is still unclear whether 
diapause is an ancestral feature of this 
lineage or if it has repeatedly evolved. 
Potentially is has independently evolved 
on at least six occasions across two 
continents — three times in Africa and 
three times in South America. There are 
three different forms of diapause, each 
occurring at distinct embryonic stages. 
Importantly, in all six killifi sh lineages 
with diapause, developmental arrest 
takes place at the same stage.
Is diapause relevant to humans? 
Apart from the fact that it is a 
fascinating evolutionary adaptation, 
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diapause may be associated with 
those that control longevity. In the 
roundworm Caenorabditis elegans, the 
genetic pathways that control diapause 
and ageing overlap. Some of these 
genes are evolutionarily conserved and 
associated with longevity in humans. 
The study of killifi sh diapause has 
potential to reveal novel longevity-
associated genes.
What happens when the rains come? 
As you might expect, the fi sh hatch. 
However, the timing is critical. Initial 
bouts of rainfall seal the dried bottom 
of the pond, and there is a delay before 
the substrate reliably retains rainwater. 
During this phase some embryos start 
to develop, but not all. A ‘bet-hedging’ 
strategy, comparable to that seen in 
plant seed banks, is observed, whereby 
the trigger to emerge from diapause is 
highly variable. Rapid hatching is risky, 
because after the initial rains, pools 
may again desiccate. In this scenario, 
undeveloped embryos would be the 
only survivors, outcompeting the 
fast-developing embryos. The highly 
unpredictable environment maintains 
variation for the trigger to emerge from 
diapause.
As their habitat is ephemeral, do 
they need to grow and mature 
quickly? Yes, annual killifi shes live 
incredibly fast lives. Among them, the 
turquoise killifi sh has taken the ‘live 
fast, die young’ strategy to an extreme 
(Figure 1). Turquoise killifi sh females 
start laying eggs as soon as 18 days 
after hatching, but then die from 
ageing-associated deterioration in just 
a few months, even in captivity. A full 
generation cycle (from adult to adult in 
the next generation) can take as little 
as 5 weeks if they skip all diapauses. 
Skipping diapause happens regularly 
in captivity if embryos are incubated at 
high temperatures. In nature, however, 
the typical life cycle takes one year. 
How can they manage to mature 
so fast? Not by a developmental 
trick. Killifi sh are not paedomorphic 
(sexually mature larvae possessing 
functional gonads), as some neotenic 
salamanders or fi sh can be. Instead, 
they become sexually mature by 
greatly speeding up the normal 
process of organ development.2015 Elsevier Ltd All rights reserved R741
